Vectura integrates formulation, device and development capabilities to offer a broad range of services to help customers bring inhaled medicines to market.

Vectura offers comprehensive services from the pre-clinical stage of development, when customers are looking to overcome complex inhaled formulation challenges, select a delivery device and move quickly to the clinic. With expertise in powder and liquid formulations, as well as a portfolio of proprietary device and formulation technologies, Vectura can help customers developing a wide range of small molecules, biologics and complex combinations. 

Optimising drug formulation and delivery device development can unlock the potential for innovative inhaled medicines that can revolutionise patients’ lives. Vectura is at the forefront of integrated drug and device development, and helping customers to deliver the inhaled therapies of the future. 

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products

Our Resources

Categories affiliated with VECTURA GROUP PLC